<p>Predicted values obtained from: A. LMM. Linear regression of the square root of OD values against log time (<i>t</i>) since the last HIV negative test (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0049661#pone.0049661.e031" target="_blank">Equation (7</a>)). B. NLMM (U). Fitting the non-linear function given by <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0049661#pone.0049661.e034" target="_blank">Equation (8</a>) to the untransformed BED OD data. C. NLMM (L). Fitting the non-linear function given by <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0049661#pone.0049661.e036" target="_blank">Equation (9</a>) to the log-transformed BED OD data. D. Using the fit describe...
Background: The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this ...
<p>(<b>A</b>) The model-inferred time since seroconversion [grey circles with 95% confidence interva...
The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this analysis) th...
<p>Fitting the non-linear function given by <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>HIV incidence (with 95% confidence intervals) in women during the period prior to their recruitme...
<p>The optical density cut-off was fixed at 0.8 for all estimates. The coefficient of variation (CoV...
<p>Clients were first seen at time 0 and then again a year later. For purposes of illustration it is...
<p>The value of ε was estimated as the proportion of cases with a BED OD<<i>C</i> among women tested...
<p>HIV incidence (with 95% confidence intervals) among women during their first year postpartum in t...
<p>Linear mixed effects model comparing HIV-1 RNA (log<sub>10</sub>) and CD4 T-cell counts between t...
Mean time since last HIV test (in years), bivariate and multivariate linear regression, by region of...
<p>A) Boxplot for the mean of log10 HIV RNA at second and third seropositive visits (∼9 and ∼15 mont...
<p>For PNP = 0 there are no “non-progressors” – <i>i.e.</i> it is assumed that every person, at some...
<p><b>(A)</b> Clinical data (circle and arrow) for all patients under study comparing against model ...
<p>The numbers of independent BED tests provided by the 353 women who seroconverted during follow-up...
Background: The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this ...
<p>(<b>A</b>) The model-inferred time since seroconversion [grey circles with 95% confidence interva...
The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this analysis) th...
<p>Fitting the non-linear function given by <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>HIV incidence (with 95% confidence intervals) in women during the period prior to their recruitme...
<p>The optical density cut-off was fixed at 0.8 for all estimates. The coefficient of variation (CoV...
<p>Clients were first seen at time 0 and then again a year later. For purposes of illustration it is...
<p>The value of ε was estimated as the proportion of cases with a BED OD<<i>C</i> among women tested...
<p>HIV incidence (with 95% confidence intervals) among women during their first year postpartum in t...
<p>Linear mixed effects model comparing HIV-1 RNA (log<sub>10</sub>) and CD4 T-cell counts between t...
Mean time since last HIV test (in years), bivariate and multivariate linear regression, by region of...
<p>A) Boxplot for the mean of log10 HIV RNA at second and third seropositive visits (∼9 and ∼15 mont...
<p>For PNP = 0 there are no “non-progressors” – <i>i.e.</i> it is assumed that every person, at some...
<p><b>(A)</b> Clinical data (circle and arrow) for all patients under study comparing against model ...
<p>The numbers of independent BED tests provided by the 353 women who seroconverted during follow-up...
Background: The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this ...
<p>(<b>A</b>) The model-inferred time since seroconversion [grey circles with 95% confidence interva...
The question of whether a score for a specific antiretroviral (e.g. lopinavir/r in this analysis) th...